RxDoctor Payments Data

Peter Kung, MD

Orthopaedic Surgery · Longview, WANPI 1225169279

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $117,730 of the $143,840 with a category attached, or 81.8%. Arthrex accounts for 94.9% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $58,428 and has fallen 95.2% since, to $2,794 in 2025. Among orthopaedic surgery clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$143,840in general payments, 2019–2025

Across 264 payments — averaging $544.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$137K
  • Steelhead Surgical Inc$6K
  • Zimmer Biomet$340
  • Left Coast Surgical Inc$208
  • Stryker$136
  • Sonex Health, Inc.$54
  • plus $128 from 4 others

What the payments were for

  • Consulting fees$1,3501%
  • Speaking & faculty fees$117,73082%
  • Travel & lodging$15,14811%
  • Food & beverage$5,8634%
  • Education$3,7503%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex218$136,521
Steelhead Surgical Inc28$6,453
Zimmer Biomet3$340
Left Coast Surgical Inc4$208
Stryker4$136
Sonex Health, Inc.1$54
Bioventus LLC3$52
RSW Medical Company, Inc.1$35
Shoulder Innovations, Inc.1$28
KCI USA, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$143,840 in reported general payments places this provider in the 90th percentile of 495 orthopaedic surgery providers in Washington.

See all orthopaedic surgery providers in Washington

Medicare billing

Part B allowed, 2024
$162,039
Medicare patients
351
Services billed
1,682

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl162$957
Ondansetron OdtOndansetron62$537
Pantoprazole Sodium82$479
Ondansetron Hcl87$381
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen31$221
Hydromorphone Hcl11$97
Mupirocin11$93
Amoxicillin20$55

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Longview

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →